Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
1.1Cardiac sensing for exercise pacing
What ifWhat if the wearable measured heart rate and used it to pace exercise?
Claim language“glucose measurement data”
Dry chest electrodes detect cardiac electrical pulses, and a timer converts the intervals between pulses to beats per minute. A wrist display cues the wearer to slow down when heart rate exceeds a preset limit and to resume the target pace when it returns to the target band.
1.2Muscle stimulation for glucose uptake
What ifWhat if the wearable used electrical muscle stimulation to increase glucose uptake through muscle contractions?
Claim language“deliver one or more metabolic-modifying agents”
Adhesive electrodes over the thigh deliver biphasic current pulses that contract the quadriceps. A timer alternates stimulation and rest intervals, and the contractions increase glucose uptake in the activated muscle.
1.4Direct glucose threshold comparison
What ifWhat if the latest glucose reading went directly to a threshold comparator that issued a suspension signal?
Claim language“generate a system state representation”
A digital comparator checks each incoming glucose value against a preset low-glucose threshold. Its output requests a temporary insulin suspension when the reading falls below that threshold.
1.5Fixed insulin suspension rules
What ifWhat if fixed rules used the current glucose estimate and its rate of change to propose an insulin suspension?
Claim language“using an adaptive control framework”
A rule table requests a temporary suspension when the glucose estimate is below a preset threshold and the estimated rate of change is negative. The rule table uses preset thresholds and a preset suspension interval on every evaluation.
1.7Adaptation from recent forecast errors
What ifWhat if recent glucose forecast errors governed the adaptation rate while swallowing-motion data drove a separate display of possible meal events?
Claim language“based on the biological context representation”
The controller compares each forecast with the glucose reading received at the forecast time and reduces its model update step when the running mean absolute error rises above a set threshold. A throat accelerometer feeds a swallow detector that places possible meal markers on the glucose display.
Section 2 · machine-generated
Variations
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Other field of use
Metabolic regulation during canine recovery
A harness worn by a dog in postoperative recovery carries a subcutaneous glucose sensor, a controller, and an infusion pump. The controller estimates glucose level and trend from sensor readings, and feeding and activity records adjust the estimated rate of meal absorption. The adaptive controller proposes a pump command, and a separate supervisor checks the command against pump status and the clinician-configured delivery profile. The actuation interface forwards validated commands to the pump.
Component substitution
Kalman filter for metabolic state estimation
An extended Kalman filter serves as the state estimator and tracks interstitial glucose, glucose rate of change, and a latent meal absorption state. The filter updates its state when a glucose reading arrives and uses recorded meal timing to update the meal absorption state. The adaptive controller converts the state estimate into a proposed delivery command. A separate supervisor checks the command before the actuation interface forwards it to the pump.
Parameter or scale variation
Dual delivery channels with timed commands
The wearable assembly contains two reservoirs, each with a metering pump and a separate flow path for its metabolic agent. The controller updates its state from glucose samples received every 5 minutes, refreshes activity context every 30 minutes, and issues a proposal with one command field per pump. Each proposal carries a 16-bit sequence number and expires 30 seconds after issuance. The supervisor checks the sequence number, expiration time, and pump readiness, then passes an accepted command pair to the actuation interface in a single transaction.
Combination with existing systems
Integration with enteral feeding equipment
A communications gateway connects the wearable controller to an enteral feeding pump and reads its delivered volume, operating state, and event timestamps. The controller combines measured feed volume with a configured carbohydrate concentration and updates the meal absorption state used to propose therapeutic delivery. An independent supervisor checks each proposal against the delivery record and the clinician-configured operating profile. The actuation interface forwards the validated command to the wearable delivery pump.
Integration with pump fault monitoring
The wearable controller connects to a pump diagnostic circuit that records motor position, line pressure, and reservoir status. The adaptive controller uses glucose measurements and activity context to propose delivery, while the safety supervisor reads actuator diagnostics through a separate interface. The supervisor checks for a latched occlusion or motor fault before releasing the command to the actuation interface. After actuation, the interface records confirmed pump movement for use in the next state update.
Automated or data-driven variant
Automatic activity context from motion sensors
A three-axis accelerometer and a heart rate sensor send data to the wearable controller. Software calculates motion energy and median heart rate over rolling windows, then passes those features to a trained classifier that outputs probabilities for rest, sustained activity, and recovery. The controller uses those probabilities to weight the glucose excursion models used to propose therapeutic delivery. An independent supervisor checks the proposal before the actuation interface sends the validated command to the pump.
Specific version of a part
Separate sensing and control processors
A low-power microcontroller timestamps glucose readings and writes them to a ring buffer in shared memory. A second microcontroller reads the buffer and runs the metabolic control calculation on a five-minute timer.
Timestamped meal context records
A receiver accepts meal records over a short-range radio link. Each record carries the estimated carbohydrate mass in grams and the meal start time, which the processor uses to calculate elapsed time since intake.
Rolling insulin delivery limit
An independent processor sums the insulin actually delivered over the preceding hour and subtracts the total from a configured one-hour limit, with the result floored at zero. It rounds the lesser of the proposed dose and the remaining allowance down to a whole pump increment and outputs that amount.
Metered pulses for pump actuation
The actuation interface converts the validated dose into a whole number of metering strokes using the calibrated volume per stroke and the stored insulin concentration. A motor driver commands one stroke at a time, and a position sensor confirms completion before the driver starts the next stroke.
Section 3 · quoted from USPTO records
Other work
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
1.1one or more physiological sensing components configured to generate physiological measurement data including at least glucose measurement data;
One or more of the data acquisition modules may receive one or more of the following types of information: continuous glucose monitoring data; insulin pump data; exercise data; and meal data.
A · US 2019/0374137 A1 · ¶ 134
The sensing arrangement 104 generally represents another medical device that includes the components of the infusion system 100 that are configured to sense, detect, measure or otherwise quantify a physiological condition of the patient, and may include a sensor, a monitor, or the like, for providing data indicative of the condition that is sensed, detected, measured or otherwise monitored by the sensing arrangement.
B · US 11,565,044 B2 · ¶ 29
1.2a therapeutic delivery subsystem configured to deliver one or more metabolic-modifying agents to the subject;
Generally, the fluid infusion device 102 includes a motor or other actuation arrangement that is operable to linearly displace a plunger (or stopper) of a reservoir provided within the fluid infusion device to deliver a dosage of fluid, such as insulin, to the body of a patient.
B · US 11,565,044 B2 · ¶ 28
1.3one or more processing modules configured to:
1.4generate a system state representation based on the physiological measurement data;
Observers will receive frequent information about metabolic measurements (such as continuous glucose or insulin), metabolic disturbances (such as meals or exercise), and metabolic treatments (such as insulin or glucagon injections).
A · US 2019/0374137 A1 · ¶ 36
For example, in a closed-loop operating mode, dosage commands may be generated based on a difference between a current (or most recent) measurement of the interstitial fluid glucose level in the body of the user and a target (or reference) glucose value.
B · US 11,565,044 B2 · ¶ 28
1.5generate a proposed therapeutic control action based on the system state representation using an adaptive control framework;
The inputs to the Safety Supervisor are {tilde over ({circumflex over (x)})}(t)=the vector of estimated metabolic states for the patient, the first component of which, {tilde over ({circumflex over (x)})}1(t), is an estimate of the patients blood glucose concentration (Short Term Observer Module) M(t)=the meal data process (from the Data Module) EX(t)=the exercise data process (from the Data Module) uref(t)=reference insulin infused at time t (produced by the Daily Profile Co
A · US 2019/0374137 A1 · ¶ 101
For example, in a closed-loop operating mode, dosage commands may be generated based on a difference between a current (or most recent) measurement of the interstitial fluid glucose level in the body of the user and a target (or reference) glucose value. In this regard, the rate of infusion may vary as the difference between a current measurement value and the target measurement value fluctuates.
B · US 11,565,044 B2 · ¶ 28
1.6receive a biological context representation indicative of a metabolic state of the subject; and
The one or more observer modules may be configured to construct and update an internal representation or estimate of a metabolic state of an individual. The one or more observer modules may be configured to transmit metabolic state information to the one or more control modules.
A · US 2019/0374137 A1 · ¶ 137
1.7condition at least one of a parameter, constraint, or internal representation of the adaptive control framework based on the biological context representation;
The Long Term Observer Module serves to produce statistical profiles of the patient's meal and exercise behavior, β and η respectively, and a circadian profile the patient's daily insulin utilization γ, which are used by other control modules to set priors on parameter estimates and/or constraints on insulin action.
A · US 2019/0374137 A1 · ¶ 57
1.8a safety supervision module configured to evaluate the proposed therapeutic control action based on one or more safety criteria and to generate a validated therapeutic control action;
The Safety Supervision Module of FIG. 4 monitors and, if necessary, modifies the suggested insulin injection signals produced by the other control modules, in an effort to (1) avoid hypoglycemia and (2) if the other modules are unable to do so, mitigate sustained hyperglycemia.
A · US 2019/0374137 A1 · ¶ 101
1.9and an actuation interface configured to control the therapeutic delivery subsystem based on the validated therapeutic control action,
The only difference between open-loop advisory operation and closed-loop control operation is in the delivery of information from the System Coordinator: in open-loop the information about insulin rate and potential for hypoglycemia is presented to the patient; in closed-loop control mode insulin delivery commands are send directly to the insulin pump.
A · US 2019/0374137 A1 · ¶ 51
Generally, the fluid infusion device 102 includes a motor or other actuation arrangement that is operable to linearly displace a plunger (or stopper) of a reservoir provided within the fluid infusion device to deliver a dosage of fluid, such as insulin, to the body of a patient.
B · US 11,565,044 B2 · ¶ 28
1.10wherein the safety supervision module is configured to intercept and evaluate the proposed therapeutic control action prior to execution by the therapeutic delivery subsystem.
The Safety Supervision Module of FIG. 4 monitors and, if necessary, modifies the suggested insulin injection signals produced by the other control modules, in an effort to (1) avoid hypoglycemia and (2) if the other modules are unable to do so, mitigate sustained hyperglycemia.
A · US 2019/0374137 A1 · ¶ 101
An empty cell means only that no passage was reproduced there.
Statements in these documents
The engineering challenge related to this problem is to design algorithms using automated insulin delivery to exert optimal closed-loop control of glucose fluctuations.
A · US 2019/0374137 A1 · ¶ 3
User flexibility—each system observer or control module could be used separately, or within an integrated control system, depending on patients' or physicians' choice;
A · US 2019/0374137 A1 · ¶ 5
However, performing such calibration measurements increases the patient burden and perceived complexity, and can be inconvenient, uncomfortable, or otherwise disfavored by patients.
B · US 11,565,044 B2 · ¶ 3
Accordingly, it is desirable to provide sensor calibration in a manner that decreases the patient burden and improves the overall user experience without compromising accuracy or reliability.
B · US 11,565,044 B2 · ¶ 3
Cite aspatent.fyi, US 2026/0354756 A1, claim 1, first published 2026-11-19T03:31:31-05:00, https://patent.fyi/US20260354756/, SHA-256 77b237c0d48937772da43bc35fe2082d2c513344799938726062ac39dd95193e